EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Vitiligo associated with type 2 immune inhibitors: FAERS analysis and literature review

Lu Lu, Jindi Feng, Shiyu Zhang iD, Huimin He, Zhonghui Hu, Lu Yang iD, Yuehua Liu, Bin Zhao, Tao Wang

The Journal of Dermatology · 2025

DOI: 10.1111/1346-8138.17698 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Dermatology, 2025. Verfasst von Lu Lu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Chin…. Hauptthemen laut MEDLINE: Vitiligo, Antibodies, Monoclonal, Humanized. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National High Level Hospital Clinical Research, Beijing Municipal Natural Science Foundation, Beijing Key Clinical Specialty Construction Project, and the National Key Clinical Specialty Project of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With the widespread use of type 2 immune response inhibitors (IRIs), there is growing concern about their association with the occurrence of vitiligo. This study aimed to comprehensively search for cases of vitiligo associated with type 2 IRIs in the US Food and Drug Administration Adverse Event Reporting System (FAERS). We retrieved the clinical characteristics of cases from January 2004 to September 2024 from the FAERS database. Disproportionality and Bayesian analyses were conducted to detect signals for vitiligo associated with type 2 IRIs. A total of 86 cases of vitiligo were identified in association with these inhibitors. The mean onset time was 326 days. Vitiligo associated with dupilumab was the most common (81.4%), with the highest reporting odds ratio (2.67, 95% confidence interval 2.11–3.4), proportional reporting ratio (2.67, χ 2 = 70.59), information component (1.38, [IC025 = 1.09), and empirical Bayes geometric mean (2.61, EBGM05 = 2.14). The link between vitiligo and type 2 IRIs underscores the need for continued pharmacovigilance to better understand these drugs and the incidence of related conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VitiligoAntibodies, Monoclonal, HumanizedHumansBayes TheoremFemaleAdverse Drug Reaction Reporting SystemsMaleUnited StatesAdultMiddle AgedUnited States Food and Drug AdministrationPharmacovigilanceYoung AdultDatabases, FactualAged

Stichwörter der Autor:innen

FAERSadverse eventdupilumabomalizumabvitiligo

Substanzen

Antibodies, Monoclonal, Humanizeddupilumab

Autor:innen und Institutionen

  • Department of Dermatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • State Key Laboratory of Complex Severe and Rare Diseases, Beijing, China.
  • National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing, China.
  • Department of Pharmacy, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
  • School of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Macau, SAR, China.

ORCID-Profile: Shiyu Zhang, Lu Yang

Förderung

  • National High Level Hospital Clinical Research
  • Beijing Municipal Natural Science Foundation
  • Beijing Key Clinical Specialty Construction Project, and the National Key Clinical Specialty Project of China
  • Natural Science Foundation of Beijing Municipality

Zitieren

APA

Lu, L., Feng, J., Zhang, S., He, H., Hu, Z., Yang, L., Liu, Y., Zhao, B., & Wang, T. (2025). Vitiligo associated with type 2 immune inhibitors: FAERS analysis and literature review. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.17698

Vancouver

Lu L, Feng J, Zhang S, He H, Hu Z, Yang L, et al. Vitiligo associated with type 2 immune inhibitors: FAERS analysis and literature review. The Journal of Dermatology. 2025. doi:10.1111/1346-8138.17698

BibTeX
@article{Lu2025,
  author = {Lu, Lu and Feng, Jindi and Zhang, Shiyu and He, Huimin and Hu, Zhonghui and Yang, Lu and Liu, Yuehua and Zhao, Bin and Wang, Tao},
  title = {Vitiligo associated with type 2 immune inhibitors: FAERS analysis and literature review},
  journal = {The Journal of Dermatology},
  year = {2025},
  doi = {10.1111/1346-8138.17698}
}
Kostenlos starten →